WuXi Biologics (WuXi Bio), a leading global contract research, development, and manufacturing organization, announced that it has again passed the GMP inspection by Japan’s Pharmaceuticals and Medical ...

WUXI, China, Feb. 27, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has ...

BEIJING, Feb. 27, 2025 /PRNewswire/ -- A news report from Beijing Review: Having reached its 2024 target, China is poised to continue promoting economic growth by exploring new drivers, analysts said.

OAKLAND, Calif., Feb. 27, 2025 /PRNewswire/ -- Hydrofast, an emerging innovator in eco-friendly home technology, is set to make its U.S. debut with two advanced countertop reverse osmosis (RO) water ...

and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection by Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its drug substance facilities ...